FDA instructs Amgen to pull Enbrel ads

02/22/2005 | NYTimes.com

The FDA ordered Amgen to pull its television ads for Enbrel, indicated for psoriasis, on grounds the advertisement did not disclose risks or mention the drug was indicated only for "chronic moderate to severe plaque psoriasis," and not milder forms. The agency also told the company its ad overstated Enbrel's effectiveness. An Amgen spokeswoman said the ad has been pulled and the company is reviewing the letter.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY